Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation - PubMed (original) (raw)
Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation
J J Hsieh et al. J Virol. 1997 Mar.
Abstract
EBNA2 is essential for immortalization of B cells by Epstein-Barr virus. EBNA2 is tethered to responsive promoters through a cellular factor, CBF1. CBF1 also binds to the activated form of mammalian Notch1, providing a linkage between EBNA2 function and Notch signalling. However, Notch2 is the predominant form expressed in spleen. The degree to which these Notch homologs are functionally convergent is not known. We present evidence that Notch2 also signals through CBF1. As is the case for Notch1, Notch2 interacted with the minimal repression domain of CBF1 and was targeted to CBF1 through the intracellular, subtransmembrane domain. Additional characterization suggested that the interaction domain of Notch may be bipartite. The intracellular domain of Notch2 (Notch2IC) located to the nucleus. This activated form of Notch2 transactivated expression of a target gene containing upstream CBF1 binding sites. The use of CBF1 mutants carrying amino acid substitutions in the transcriptional repression domain revealed that activation of gene expression by Notch2 is also based on masking of CBF1-mediated repression. Targeting of Notch1 and targeting of Notch2 were found to be identical and distinguishable from targeting by EBNA2. Mutation of CBF1 at codons 249 to 251 abolished interaction with both Notch proteins but not with EBNA2. In a biological examination of Notch2 function in muscle cells, Notch2IC activated endogenous HES-1 gene expression and blocked muscle cell differentiation. Overall, the data imply that at least a subset of the intracellular events following signalling in cells expressing Notch2 are common to those in Notch1-expressing cells. The concept that EBNA2 functions by mimicking Notch signalling is therefore viable whether cells are expressing Notch1 or Notch2.
Similar articles
- The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
Gross H, Barth S, Pfuhl T, Willnecker V, Spurk A, Gurtsevitch V, Sauter M, Hu B, Noessner E, Mueller-Lantzsch N, Kremmer E, Grässer FA. Gross H, et al. Int J Cancer. 2011 Sep 1;129(5):1105-15. doi: 10.1002/ijc.25760. Epub 2011 Jan 12. Int J Cancer. 2011. PMID: 21710493 - Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.
Kohlhof H, Hampel F, Hoffmann R, Burtscher H, Weidle UH, Hölzel M, Eick D, Zimber-Strobl U, Strobl LJ. Kohlhof H, et al. Blood. 2009 May 28;113(22):5506-15. doi: 10.1182/blood-2008-11-190090. Epub 2009 Apr 1. Blood. 2009. PMID: 19339697 - Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2.
Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD. Hsieh JJ, et al. Mol Cell Biol. 1996 Mar;16(3):952-9. doi: 10.1128/MCB.16.3.952. Mol Cell Biol. 1996. PMID: 8622698 Free PMC article. - Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.
Strobl LJ, Höfelmayr H, Stein C, Marschall G, Brielmeier M, Laux G, Bornkamm GW, Zimber-Strobl U. Strobl LJ, et al. Immunobiology. 1997 Dec;198(1-3):299-306. doi: 10.1016/s0171-2985(97)80050-2. Immunobiology. 1997. PMID: 9442401 Review. - EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.
Zimber-Strobl U, Strobl LJ. Zimber-Strobl U, et al. Semin Cancer Biol. 2001 Dec;11(6):423-34. doi: 10.1006/scbi.2001.0409. Semin Cancer Biol. 2001. PMID: 11669604 Review.
Cited by
- A network of Notch-dependent and -independent her genes controls neural stem and progenitor cells in the zebrafish thalamic proliferation zone.
Sigloch C, Spitz D, Driever W. Sigloch C, et al. Development. 2023 Apr 1;150(7):dev201301. doi: 10.1242/dev.201301. Epub 2023 Apr 3. Development. 2023. PMID: 37009986 Free PMC article. - EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
Su C, Lu F, Soldan SS, Lamontagne RJ, Tang HY, Napoletani G, Farrell PJ, Tempera I, Kossenkov AV, Lieberman PM. Su C, et al. PLoS Pathog. 2021 Aug 5;17(8):e1009834. doi: 10.1371/journal.ppat.1009834. eCollection 2021 Aug. PLoS Pathog. 2021. PMID: 34352044 Free PMC article. - Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus.
Hutcheson RL, Chakravorty A, Sugden B. Hutcheson RL, et al. Front Cell Infect Microbiol. 2021 Jan 11;10:606412. doi: 10.3389/fcimb.2020.606412. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33505922 Free PMC article. Review. - Downregulation of Hes1 expression in experimental biliary atresia and its effects on bile duct structure.
Zhang RZ, Zeng XH, Lin ZF, Ming-Fu, Tong YL, Lui VC, Tam PK, Lamb JR, Xia HM, Chen Y. Zhang RZ, et al. World J Gastroenterol. 2018 Aug 7;24(29):3260-3272. doi: 10.3748/wjg.v24.i29.3260. World J Gastroenterol. 2018. PMID: 30090006 Free PMC article. - Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
Szymula A, Palermo RD, Bayoumy A, Groves IJ, Ba Abdullah M, Holder B, White RE. Szymula A, et al. PLoS Pathog. 2018 Feb 20;14(2):e1006890. doi: 10.1371/journal.ppat.1006890. eCollection 2018 Feb. PLoS Pathog. 2018. PMID: 29462212 Free PMC article.
References
- Development. 1991 May;112(1):231-40 - PubMed
- Genes Dev. 1992 Mar;6(3):345-55 - PubMed
- J Virol. 1992 May;66(5):2846-52 - PubMed
- Cell. 1992 Jun 26;69(7):1199-212 - PubMed
- EMBO J. 1993 Jan;12(1):167-75 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous